
|Articles|December 4, 2004
Cymbalta receives FDA OK for depression maintenance
Duloxetine approved for maintenance of MDD
Advertisement
Eli Lilly & Co. has received regulatory word that antidepressant duloxetine (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
2
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
3
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
4


























































































































































